Stents are important Class III medical devices that are useful to clear blockages in the arteries. Typically, these blockages are called ‘lesions’ in medical terminology. A stent is a small mesh that widens the narrowed down blood vessel and improves the normal flow of blood. While coronary stent was an unregulated market in India till 2016, some restrictions regarding the price cap were implemented in 2017. Although more than 60% of the stents used in India are imported, there are a few active indigenous players which drive domestic production of stents.
Here is a list of all major Indian stent manufacturers.
The company has 3 types of stents in its product profile.
- Self Expanding Metal Stents:
- Honto Pseudo-cyst stents:
- Bravo Bronchial Y-stent:
Supraflex Cruz is the trademark coronary stent by SMT. It is a Sirolimus drug-eluting Cobalt-Chromium stent. Sirolimus is a drug used to coat the stent that prevents restenosis after balloon angioplasty. If ‘restenosis’ is too technical for you, it basically means recurrence of narrowing (or blockage) of the artery even after the stent is deployed.
Since the Supraflex stents are made from Cobalt-chromium (60L) alloys, these stents are not as much shaped memory-driven as the Nitinol stents.
Indian Stent Market Insights
After the capping of the stent prices in India, there is not much difference between the bare-metal stents and drug-eluting stents (DES). While bare-metal stents cost nearly INR 10,000, the DES ones cost anywhere between INR 20,000-30,000. Before 2016, there used to be a huge price difference between the two types of stents.
Since Drug-eluting stents are proven to be better than bare metal ones in terms of their effectiveness and they are no longer very expensive, there is a decline in the usage of bare-metal stents in India. According to a report, there has been a decline of 30% in the use of bare-metal stents between 2017 and 2018.
- Is The Colonial Mentality Hindering India’s Success? - 4th September 2021
- 5G Indian Stocks To Buy: Be an Early Bird Investor - 12th May 2021
- Spanish Index IBEX 35 is an Untapped Goldmine in 2021 - 11th May 2021